Coverage Policies

Use the index below to search for coverage information on specific medical conditions.

QualChoice reserves the right to alter, amend, change or supplement medical policies as needed. QualChoice reviews and authorizes services and substances. CPT and HCPCS codes are listed as a convenience and any absent, new or changed codes do not alter the intent of the policy.

High-Tech Imaging: High-Tech Imaging services are administered by National Imaging Associates, Inc. (NIA). For coverage information and authorizations, click here.

Medical Providers: Payment for care or services is based on eligibility, medical necessity and available benefits at time of service and is subject to all contractual exclusions and limitations, including pre-existing conditions if applicable.

Future eligibility cannot be guaranteed and should be rechecked at time of service. Verify benefits by signing into My Account or calling Customer Service at 800.235.7111 or 501.228.7111.

QualChoice follows care guidelines published by MCG Health.

INDEX:
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Effective Date: 09/01/2017 Title: Pulmonary Function Testing
Revision Date: 01/01/2020 Document: BI542:00
CPT Code(s): 94010, 94060, 94070, 94150, 94200, 94250, 94375, 94617-94618, 94621, 94680, 94681, 94690, 94726, 94727, 94728, 94729, 94770
Public Statement

Effective Date:

a)    This policy will apply to all services performed on or after the above revision date which will become the new effective date.

b)    For all services referred to in this policy that were performed before the revision date, contact customer service for the rules that would apply.

1)    Pulmonary function tests (PFTs) can be performed in a variety of clinical situations.  PFTs, such as spirometry are routinely used for confirming or monitoring a diagnosis of asthma or COPD. 

2)    Specialized PFTs with known risks (challenge tests or stress tests) require prior authorization unless ordered or performed by a pulmonologist.

3)    There is no evidence supporting the routine use of PFTs for preoperative evaluation.


Medical Statement

Pulmonary function tests include:

·         Spirometry,

·         Lung Volume,

·         Diffusion Capacity, 

·         Lung compliance,

·         Pulmonary Studies during Exercise Testing.

A. Simple spirometry is the mainstay of pulmonary function testing and is usually sufficient to differentiate between obstructive and restrictive disorders. It helps in evaluating obstructive lung diseases such as asthma and chronic obstructive pulmonary disease (COPD) for severity and response to therapy. Additional pulmonary function testing is usually not necessary for adequate clinical assessment.

B. Lung volume tests are most useful for assessing restrictive lung diseases such as those caused by scarring of lungs or by abnormalities in the ribcage or muscles of the chest wall.

C. Diffusion capacity is used to differentiate between chronic bronchitis, emphysema, and asthma in patient with obstructive patterns, and evaluate pulmonary involvement in systemic diseases (e.g., rheumatoid arthritis, systemic lupus).

D. Lung compliance testing is an invasive test. It is performed only when all other PFTs give equivocal results. It measures the elastic recoil/stiffness of the lungs, and requires patient to swallow an esophageal balloon.

E. Pulmonary stress testing is done in two forms:

1)  Simple pulmonary stress testing is a test that allows quantification of workload and heart rate activity, while measuring the degree of oxygen desaturation. This test is undertaken to measure the degree of hypoxemia or desaturation that occurs with exertion and to optimize titration of supplemental oxygen for the correction of hypoxemia.

2)  A more complex test involves the measurements of oxygen uptake, CO2 production, and O2 for following: to distinguish between cardiac and pulmonary causes for dyspnea; determine the need for and dose of ambulatory oxygen; assist in developing a safe exercise prescription for patients with cardiovascular or pulmonary disease; predict the morbidity of lung resection; or titrate optimal settings in selected patients who have physiologic pacemakers.

F. The use of spirometry, bronchodilation spirometry, respiratory volume flow loop, vital capacity, maximum breathing capacity or plethysmography for lung volumes, diffusing capacity to diagnose or manage patients with asthma or COPD is considered medically necessary and does not require prior authorization.

G. For any advanced pulmonary function testing a pulmonologist consultation should be considered. Unless ordered or performed by a pulmonologist, less commonly used Pulmonary Function tests including following require prior authorization:

   i)  Bronchospasm provocation testing

   ii)  Exercise test for bronchospasm

   iii)  Pulmonary stress testing, with measurement of heart rate, oximetry, & oxygen    

         titration

    iv)   Cardiopulmonary exercise testing

    v)  Oxygen uptake, expired gas analysis; rest & exercise

     vi)  Carbon dioxide, expired gas determination by infrared analyzer

H. Pulmonary Function Testing is not considered medically necessary and not covered when:

1)   A diagnosis or evaluation can be made clinically; or

2)   When test results are not necessary to manage the patient’s disease; or

3)    On routine visits for other medical conditions, when there is no signs and symptoms of clinically meaningful changes in pulmonary status; or

4)    Routine use of PFTs at each office visit; or

5)    Spirometry is the main test, additional testing without above indications.

 

Codes Used In This BI:

94010

Spirometry, incl graphic record, total & timed vital capacity, expiratory flow rate measurement(s), w/ or w/out max voluntary ventilation

94060

Bronchodilation responsiveness, spirometry as in 94010, pre & post-bronchodilator admin

94070

Bronchospasm provocation eval, mult spirometric determinations as in 94010, w/admin agents

94150

Vital capacity, total (separate procedure)

94200

Maximum breathing capacity, maximal voluntary ventilation

94375

Respiratory flow volume loop

94617

Exercise test for bronchospasm, including pre- and post-spirometry and pulse oximetry; with electrocardiographic recording(s) (code revised eff 01-01-2021)

94618

Pulmonary stress testing, incl measurement of heart rate, oximetry, & oxygen titration, when perf

94620

Pulmonary stress testing, simple (deleted 1/1/18)

94621

Cardiopulmonary exercise testing, incl measurements of minute ventilation, CO₂ production, O₂ uptake, & electrocardiographic recordings (revised 1/1/18)

94680

Oxygen uptake, expired gas analysis; rest & exercise, direct, simple

94681

        including CO₂ output, percentage O₂ extracted

94690

        rest, indirect (separate procedure)

94726

Plethysmography for deter of lung volumes &, when perf, airway resistance

94727

Gas dilution or washout for deter of lung volumes &, when perf, distrib of ventilation & closing volumes

94728

AIRWAY RESISTANCE BY OSCILLOMETRY (code revised eff 01/01/2020)

+

94729

Diffusing capacity

 

94770

Carbon dioxide, expired gas determination by infrared analyzer (code deleted eff 01-01-2021)

 

94250

- Expired gas collection, quantitative, single procedure (code delete eff 01-01-2021)


Limits

Pulmonary function testing is not covered for routine preoperative evaluations.


Reference

1)    Qaseem A, et al. Risk Assessment for and Strategies to Reduce Perioperative Pulmonary Complications for Patients Undergoing Noncardiothoracic Surgery: A Clinical Guideline from the American College of Physicians. Ann Intern Med. 2006; 144(8):575-580.

2)    Colice GL, et al. Physiologic Evaluation of the Patient With Lung Cancer Being Considered for Resectional Surgery: ACCP Evidence-Based Clinical Practice Guidelines (2nd Edition). Chest. 2007; 132(3_suppl):161S-177S.

3)    Pulmonary Function testing – Medicare Local Coverage Determination (LCD) – Noridian  https://med.noridianmedicare.com/documents/10525/5321621/Local+Coverage+Determination+for+Pulmonary+Function+Testing+%28L34247%29

Addendum:

1)    Effective 11/01/2017: Added that pulmonary function tests require prior authorization unless performed by a pulmonologist.

2)    Effective 1/1/2018: 2018 Code Updates. Deleted CPT code 94620 from Claim Statement section. This code was replaced with new CPT codes 94617 – 94618.

3)    Effective 08/01/2018: Removed PA requirements for some PFT’s (94726-94729).

4)    Effective 01/01/2020: Code update: Code 94728 revised eff 01/01/2020.

5)    Effective 01/01/2021: Updated code 94617 and deleted codes 94250 and 94770, and separated code ranges in search box to make searchable.


Application to Products
This policy applies to all health plans administered by QualChoice, both those insured by QualChoice and those that are self-funded by the sponsoring employer, unless there is indication in this policy otherwise or a stated exclusion in your medical plan booklet. Consult the individual plan sponsor Summary Plan Description (SPD) for self-insured plans or the specific Evidence of Coverage (EOC) for those plans insured by QualChoice. In the event of a discrepancy between this policy and a self-insured customer’s SPD or the specific QualChoice EOC, the SPD or EOC, as applicable, will prevail. State and federal mandates will be followed as they apply.
Changes: QualChoice reserves the right to alter, amend, change or supplement benefit interpretations as needed.
This policy has recently been updated. Please use the index above or enter policy title in search bar for the latest version.